Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER

What to Check When Your PT-141 (Bremelanotide) Arrives

Not every irregularity on arrival is a defect, and not every compound is defective under the same conditions. Here is what actually matters when a PT-141 (Bremelanotide) shipment arrives.

Cyclic heptapeptide, melanocortin receptor agonistReproductiveMetabolic

In plain English

Check for an intact white cake and evidence the packaging kept light out. Yellowing indicates light damage and is the relevant reason to reject a vial of this compound.

What PT-141 (Bremelanotide) actually is

PT-141 has an unusual history. It is a breakdown product of a compound originally developed for research into skin pigmentation, and an unexpected observation during that work redirected attention to the breakdown product, which was then developed as its own line of research.

Supplied for laboratory research use only — not for human or animal use.

Research-grade PT-141 (Bremelanotide)

Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.

Technical detail below

Arrival inspection for PT-141 (Bremelanotide)

Check for an intact white cake and evidence of light-protective packaging. Yellowing indicates tryptophan oxidation and is the relevant rejection signal for this compound.

Storage on arrival

On receiptSealed at -20 °C, dry and protected from light.
Once reconstitutedRefrigerate at 2–8 °C, protected from light on account of the tryptophan residue.
Working windowCommonly worked with for 2–4 weeks at 2–8 °C.

Documentation to check

Confirm the mass near 1025.2 Da and check for oxidised (+16 Da) species from the tryptophan. Also confirm the cyclic form: a linear (uncyclised) impurity differs by 18 Da from the cyclised product, since ring closure eliminates a water molecule.

What PT-141 (Bremelanotide) is studied for

Melanocortin receptor pharmacology

Acts at melanocortin receptors, with MC3R and MC4R the subtypes of research interest.

Central rather than peripheral mechanism

Distinguished in the literature by acting centrally, unlike vascular-mechanism compounds in adjacent research areas.

Melanotan II lineage

Its origin as a metabolite of a pigmentation-research compound is central to understanding its development history.

Cyclic constraint

The lactam bridge restricts conformational freedom, a common strategy for improving receptor selectivity.

Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.

More PT-141 (Bremelanotide) reference

Shipping & Receiving reference for other compounds

PT-141 (Bremelanotide) overview PT-141 (Bremelanotide) calculatorPT-141 (Bremelanotide) product details

PT-141 (Bremelanotide) is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.